Zee Ying Kiat

Dr Zee Ying Kiat is a medical oncologist at Mount Elizabeth Hospital, Singapore. He is well-versed in general medical oncology and has special interests in gastro-oesophageal, hepatobiliary, pancreatic, and colorectal cancers. He was a consultant medical oncologist at the National University Cancer Institute, Singapore (NCIS). Dr Zee graduated from the University College London, UK. He worked at the Royal Marsden Hospital in London before completing specialist training in medical oncology at the National University Hospital. He subsequently underwent fellowship training at The Christie Hospital and Paterson Institute for Cancer Research in Manchester, UK, where his focus was on anti-cancer drug development. He is a member of the American Society of Clinical Oncology and founding member of the Hepatopancreatobiliary Association of Singapore. He is the board member of the Mount Elizabeth Hospital’s medical advisory board, the National Healthcare Group's domain specific review board and the chapter of medical oncologists, College of Physicians, Singapore. His commitment to research has been recognised through various grants including the National Medical Research Council’s clinician investigator support grant and NCIS investigator protected time grant. At NCIS, he conducted clinical and translational research as principal or co-investigator in local and international trials involving novel targeted therapies for colorectal, gastric, liver and pancreatic cancers. He has published his work as first author in various journals including the British Journal of Cancer, Journal of Clinical Oncology, Lancet Oncology and Nature Reviews. Dr Zee is a recipient of the Excellent Service Award from SPRING Singapore.